ACE and COVID-19: One study examining patients with COVID-19 showed that a lower level of serum ACE on admission was an independent risk factor for disease progression, while an ACE level of ≤33.5 U/L predicted a higher cumulative viral RNA and was associated with increased proinflammatory mediator levels and decreased lymphocyte counts [7].